Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2

BACKGROUND: Ginsenoside compound K(C-K), a major metabolite of ginsenoside, exhibits anticancer activity in various cancer cells and animal models. A cell signaling study has shown that C-K inhibited nuclear factor-kappa B (NF-κB) pathway in human astroglial cells and liver cancer cells. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu-Shi, Zhu, Hongyan, Li, He, Li, Yang, Zhao, Bing, Jin, Ying-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606818/
https://www.ncbi.nlm.nih.gov/pubmed/31308817
http://dx.doi.org/10.1016/j.jgr.2018.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606818/
https://www.ncbi.nlm.nih.gov/pubmed/31308817
http://dx.doi.org/10.1016/j.jgr.2018.04.002

Ejemplares similares